VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AUNAAuna S.A.
$5.13$380M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAUNAP/E History

AUNA logoAuna S.A. (AUNA) P/E Ratio History

Undervalued

Trading at 5.7x vs 5Y avg 11.5x · 80th percentile · Below historical baseline · Data 2024–2025

Current P/E (TTM)
5.7x
-51% vs 5Y avg
5Y Avg P/E
11.5x
Median 3.3x
5Y Percentile
80th
Upper end of range
PEG Ratio
N/A
5-Year P/E Range
5.7x
Min1.9xMedian3.3xMax44.7x
TTM EPS$0.94
Price$5.13
Earnings Yield17.64%
EPS Growth (1Y)87.7%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 20, 2026, Auna S.A. (AUNA) trades at a price-to-earnings ratio of 5.7x, with a stock price of $5.13 and trailing twelve-month earnings per share of $0.94.

The current P/E is 51% below its 5-year average of 11.5x. Over the past five years, AUNA's P/E has ranged from a low of 1.9x to a high of 44.7x, placing the current valuation at the 80th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, AUNA trades at a 74% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, AUNA trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AUNA DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

AUNA Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
5.7vs22.1
-74%
Below Sector
vs. S&P 500
5.7vs24.4
-77%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 88% EPS growth (1Y)

AUNA P/E vs Peers

Hospitals and inpatient facilities peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
UHS logoUHSUniversal Health Services, Inc.
$9B6.10.38+37%
THC logoTHCTenet Healthcare Corporation
$15B11.10.34Best-53%
CYH logoCYHCommunity Health Systems, Inc.
$426M0.8Lowest-+197%Best
HCA logoHCAHCA Healthcare, Inc.
$84B13.20.63+29%
AMSF logoAMSFAMERISAFE, Inc.
$589M12.7--15%
SEM logoSEMSelect Medical Holdings Corporation
$2B14.0--29%
ENSG logoENSGThe Ensign Group, Inc.
$9B26.31.91+14%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

AUNA Historical P/E Data (2024–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Dec 31 2025$4.92$0.1144.7x+289%
FY2025 Q3-$6.72$2.532.7x-77%
FY2025 Q2Jun 30 2025$6.20$3.201.9x-83%
FY2025 Q1Mar 31 2025$7.11$2.163.3x-71%
FY2024 Q4-$6.86$1.404.9x-57%

Average P/E for displayed period: 11.5x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

2+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AUNA — Frequently Asked Questions

Quick answers to the most common questions about buying AUNA stock.

What is AUNA's P/E ratio?

Auna S.A. (AUNA) trailing twelve-month P/E ratio is 5.7x, based on TTM diluted EPS of $0.94. The 5-year average P/E is 11.5x and the historical range spans 1.9x to 44.7x.

Is AUNA stock overvalued or undervalued?

AUNA trades at 5.7x P/E, below its 5-year average of 11.5x. At the 80th percentile of its historical range (1.9x–44.7x), the stock is priced at a discount to its own history.

Is AUNA stock expensive?

No, AUNA is not expensive on a historical basis. The current P/E of 5.7x is below the 5-year average of 11.5x and sits at the 80th percentile of its valuation range.

What is AUNA's historical P/E range?

Over the past 5 years, AUNA's P/E ratio has ranged from 1.9x to 44.7x, with a median of 3.3x and an average of 11.5x. The current P/E of 5.7x places the stock at the 80th percentile of this range. Full historical data spans 2024–2025.

How does AUNA's P/E compare to the S&P 500?

AUNA trades at 5.7x P/E versus the S&P 500 median of 24.4x. The 77% discount to the market suggests lower growth expectations or perceived higher risk.

How does AUNA's valuation compare to Healthcare peers?

Auna S.A. P/E of 5.7x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is AUNA's PEG ratio?

AUNA PEG ratio is N/A, based on a P/E of 5.7x and EPS growth of 87.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is AUNA's earnings yield?

AUNA earnings yield is 17.64%, the inverse of its 5.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

AUNA P/E Ratio History (2024–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current44.7x
Period Avg11.5x
Range1.9x - 44.7x
Change+814%
5 quartersDec 31, 2024 - Dec 31, 2025